Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Among authors: harvey ja. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Olivotto IA, Link E, Phillips C, Whelan TJ, Bryant G, Kunkler IH, Westenberg AH, Purohit K, Ahern V, Graham PH, Akra M, McArdle O, Ludbrook JJ, Harvey JA, Maduro JH, Kirkove C, Gruber G, Martin JD, Campbell ID, Delaney GP, Chua BH; BIG 03-07/TROG 07.01 trial investigators. Olivotto IA, et al. Among authors: harvey ja. Radiother Oncol. 2020 Jan;142:180-185. doi: 10.1016/j.radonc.2019.07.024. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431385
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
Digital photography as source documentation of skin toxicity: an analysis from the Trans Tasman Radiation Oncology Group (TROG) 04.01 post-mastectomy radiation skin care trial.
Graham PH, Plant NA, Graham JL, Browne LH, Borg M, Capp A, Delaney GP, Harvey J, Kenny L, Francis M, Zissiadis Y. Graham PH, et al. J Med Imaging Radiat Oncol. 2012 Aug;56(4):458-63. doi: 10.1111/j.1754-9485.2012.02365.x. Epub 2012 May 25. J Med Imaging Radiat Oncol. 2012. PMID: 22883656 Clinical Trial.
A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01.
Graham PH, Plant N, Graham JL, Browne L, Borg M, Capp A, Delaney GP, Harvey J, Kenny L, Francis M, Zissiadis Y. Graham PH, et al. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):45-50. doi: 10.1016/j.ijrobp.2012.12.009. Epub 2013 Feb 12. Int J Radiat Oncol Biol Phys. 2013. PMID: 23414763 Clinical Trial.
The effect of imaging modality (magnetic resonance imaging vs. computed tomography) and patient position (supine vs. prone) on target and organ at risk doses in partial breast irradiation.
Brown E, Dundas K, Surjan Y, Miller D, Lim K, Boxer M, Ahern V, Papadatos G, Batumalai V, Harvey J, Lee D, Delaney GP, Holloway L. Brown E, et al. J Med Radiat Sci. 2021 Jun;68(2):157-166. doi: 10.1002/jmrs.453. Epub 2020 Dec 7. J Med Radiat Sci. 2021. PMID: 33283982 Free PMC article.
Comparison of Magnetic Resonance Imaging and Computed Tomography for Breast Target Volume Delineation in Prone and Supine Positions.
Pogson EM, Delaney GP, Ahern V, Boxer MM, Chan C, David S, Dimigen M, Harvey JA, Koh ES, Lim K, Papadatos G, Yap ML, Batumalai V, Lazarus E, Dundas K, Shafiq J, Liney G, Moran C, Metcalfe P, Holloway L. Pogson EM, et al. Among authors: harvey ja. Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):905-912. doi: 10.1016/j.ijrobp.2016.08.002. Epub 2016 Aug 11. Int J Radiat Oncol Biol Phys. 2016. PMID: 27788960
The impact of imaging modality (CT vs MRI) and patient position (supine vs prone) on tangential whole breast radiation therapy planning.
Dundas K, Pogson EM, Batumalai V, Delaney GP, Boxer MM, Yap ML, Ahern V, Chan C, David S, Dimigen M, Harvey JA, Koh ES, Lim K, Papadatos G, Lazarus E, Descellar J, Metcalfe P, Holloway L. Dundas K, et al. Among authors: harvey ja. Pract Radiat Oncol. 2018 May-Jun;8(3):e87-e97. doi: 10.1016/j.prro.2017.07.007. Epub 2017 Jul 14. Pract Radiat Oncol. 2018. PMID: 28993138
Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
Penniment MG, De Ieso PB, Harvey JA, Stephens S, Au HJ, O'Callaghan CJ, Kneebone A, Ngan SY, Ward IG, Roy R, Smith JG, Nijjar T, Biagi JJ, Mulroy LA, Wong R; TROG 03.01/CCTG ES.2 group. Penniment MG, et al. Among authors: harvey ja. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):114-124. doi: 10.1016/S2468-1253(17)30363-1. Epub 2017 Dec 14. Lancet Gastroenterol Hepatol. 2018. PMID: 29248399 Clinical Trial.
523 results